Condition

Stage IV Uterine Corpus Cancer AJCC v7

ClinicalTrials.gov condition label

Clinical trials2

Recruiting1

Common interventions7

Lead sponsors shown2

Clinical trials

2 shown

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionNCT05334069 · 2022-08-18

RECRUITING

mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and OvarianNCT02208375 · 2014-11-11

ACTIVE_NOT_RECRUITING

Common interventions

Biospecimen CollectionPROCEDURE1CapivasertibDRUG1Laboratory Biomarker AnalysisOTHER1OlaparibDRUG1Pharmacological StudyOTHER1Questionnaire AdministrationOTHER1VistusertibDRUG1

Leading sponsors

Alliance for Clinical Trials in Oncology1M.D. Anderson Cancer Center1

Trial status mix

ACTIVE_NOT_RECRUITING1

RECRUITING1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.